Shandong Sito Bio-technology Co., Ltd.

SZSE:300583.SZ

16.34 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 198.384322.254244.396356.558259.57328.87334.786379.159296.71382.596253.647320.546258.469351.232272.376188.179232.089270.748222.171179.006206.999292.475287.321205.137286.509319.951240.68282.302197.437202.757103.071186.854118.031216.21147.149180.744
Cost of Revenue 142.79245.574174.821309.463201.135237.841245.803340.056222.41299.167177.669263.315191.296276.082206.343172.828196.313252.13184.31146.36142.044219.493222.185151.249231.962235.992165.554195.878164.253160.43882.374377.21876.34139.45922.09372.528
Gross Profit 55.59476.6869.57447.09558.43591.02888.98239.10374.29983.42975.97857.23167.17375.1566.03315.35135.77618.61837.86132.64664.95572.98265.13753.88854.54783.95975.12686.42333.18442.31920.697-190.36441.69176.75225.059-191.784
Gross Profit Ratio 0.280.2380.2850.1320.2250.2770.2660.1030.250.2180.30.1790.260.2140.2420.0820.1540.0690.170.1820.3140.250.2270.2630.190.2620.3120.3060.1680.2090.201-1.0190.3530.3550.531-1.061
Reseach & Development Expenses 9.89517.17514.32213.34913.81413.91413.99918.34712.18812.5347.13715.598.43514.4211.28619.9538.2319.4287.39624.83311.71213.375.8725.2475.64622.0076.5214.3877.28710.306019.147010.271022.673
General & Administrative Expenses 68.251-7.71131.757-61.6680.04-11.89836.344-61.05278.033-16.27836.563-50.95659.578-6.86233.562-67.15429.303-19.35741.311-21.11320.601-6.14516.744-9.20113.428-15.97525.062-30.48515.644-3.64811.5269.64612.748-7.96912.84546.363
Selling & Marketing Expenses 8.7815.024.1623.9513.5184.3353.8625.9062.4192.8663.423-1.584.2628.262.8133.2523.8466.5591.826.3791.6962.172.0011.2612.1813.9272.6033.1072.652.8212.6151.0642.0931.4611.3785.839
SG&A 77.032-2.69135.92-57.70983.558-7.56240.206-55.14680.452-13.41339.986-52.53663.841.39936.375-63.90233.149-12.79743.131-14.73422.297-3.97518.744-7.9415.609-12.04827.664-27.37818.294-0.82714.14110.7114.841-6.50814.22255.522
Other Expenses -33.14-0.437-0.001-3.458-0.30224.4990.002-1.123-0.156-0.009-0.026-1.393-0.0460.037-0.282-4.849-0.216-0.469-0.757-2.5340.0250.029-0.008-0.362-0.002-0.0240.006-1.2310.1660.5550.1121.0270.0280.0450.342239.047
Operating Expenses 53.78759.54250.10436.36754.42153.10156.88244.55146.9848.85348.7542.32337.12642.31546.76559.03142.34334.80650.9459.64534.51531.14123.88330.79622.50839.29728.9531.01820.48522.62815.21214.70115.41116.28714.562239.047
Operating Income 1.80711.2938.082-14.7721.6825.88419.947-4.2079.95229.41414.06613.4319.11128.105-4.673-132.112-11.99-13.781-28.274-29.52324.21134.75537.75127.72334.88853.2534.06854.25420.82624.1674.55633.07522.00552.0977.24947.263
Operating Income Ratio 0.0090.0350.033-0.0410.0060.0790.06-0.0110.0340.0770.0550.0420.0740.08-0.017-0.702-0.052-0.051-0.127-0.1650.1170.1190.1310.1350.1220.1660.1420.1920.1050.1190.0440.1770.1860.2410.1540.261
Total Other Income Expenses Net -0.01-0.437-0.001-3.458-0.30224.4990.002-1.123-0.156-0.009-0.026-1.393-0.0460.037-0.282-4.849-0.216-0.469-0.757-2.5340.0250.029-0.008-0.362-0.004-0.0070.008-1.231-0.0660.4180.1121.0270.0280.0450.342-0.08
Income Before Tax 1.79710.8568.081-18.2311.37850.38319.949-5.339.79629.40514.0412.03719.06628.141-4.955-136.961-12.206-14.251-29.032-32.05724.23734.78437.74327.36134.88553.22634.07453.02320.99124.5854.66834.08822.03252.1427.59147.183
Income Before Tax Ratio 0.0090.0340.033-0.0510.0050.1530.06-0.0140.0330.0770.0550.0380.0740.08-0.018-0.728-0.053-0.053-0.131-0.1790.1170.1190.1310.1330.1220.1660.1420.1880.1060.1210.0450.1820.1870.2410.1610.261
Income Tax Expense 1.5681.5964.3691.0320.3481.1282.424-8.0951.6879.5232.3186.4586.8855.0590.1-6.6261.3421.9310.5221.334.9443.5535.8341.1234.76512.5854.1247.5265.2933.2991.3954.8723.8398.8821.9114.166
Net Income 1.50410.1413.071-15.5531.1944.61215.3550.6748.96719.59912.744.62312.57824.375-5.371-130.681-12.075-12.807-24.243-27.9219.79231.39232.04527.07929.81440.37829.57746.87517.20223.5964.32928.80919.70646.0596.60343.017
Net Income Ratio 0.0080.0310.013-0.0440.0050.1360.0460.0020.030.0510.050.0140.0490.069-0.02-0.694-0.052-0.047-0.109-0.1560.0960.1070.1120.1320.1040.1260.1230.1660.0870.1160.0420.1540.1670.2130.140.238
EPS 0.0080.0540.02-0.0820.0060.250.090.0040.0520.110.0750.0250.0750.14-0.031-0.76-0.071-0.079-0.22-0.170.190.180.30.160.270.240.270.270.160.150.0410.220.250.360.0830.34
EPS Diluted 0.0080.0540.02-0.0820.0060.250.090.0040.0520.110.0750.0250.0750.14-0.031-0.76-0.07-0.079-0.22-0.170.190.180.30.160.270.240.270.270.160.150.0410.220.250.360.0830.34
EBITDA 8.02423.59861.36436.39652.91298.40472.97542.25856.49478.64766.63351.96559.5764.99920.395-75.38416.3825.654-10.87-8.00934.08160.80661.56828.07246.78245.30461.00782.16515.8531.5427.836-253.14426.94360.78110.497-256.527
EBITDA Ratio 0.040.0730.0870.0180.0230.1910.10300.0990.0920.1090.0490.1190.0950.075-0.155-0.02-0.051-0.049-0.1590.1640.1570.1550.1370.1330.1290.2530.2530.080.1280.076-1.3550.2280.2810.2-1.419